BPC-157 is not FDA approved, and research is ongoing
Int J Mol Med 45(2):441450
ARA-290 peptide is sourced by research teams investigating the innate repair receptor a heteromeric receptor complex distinct from the classical erythropoietin receptor and its associated intracellular signaling cascades in controlled in vitro environments
It is technically not a peptide, but it sits next to peptides on the same prescribing menu, and it pairs well with surgical recovery
Instead, it supports muscle growth indirectly by accelerating tissue recovery, reducing chronic inflammation, strengthening tendons and ligaments, and improving gut health for better nutrient absorption
BPC-157 is an experimental peptide, and it has not been approved by the FDA to diagnose, treat, cure, or prevent any disease